Crowdfunding

CNS Pharmaceuticals, Inc.

withdrawn 2018-10-26

Tier2 · Equity (common or preferred stock), Security to be acquired upon exercise of option, warrant or other right to acquire security · Audited · Healthcare

CIK 1729427
File 024-10855
State NV
SIC 2834

Offering: —; no 1-A states an amount
Reported Sold: —; no 1-K or 1-Z states a sold amount
Filings: 4; across 1 offering

Connected

named in its Form 1-A filings

auditorGBH CPAs, PC legalSchiff Hardin LLP underwriterBoustead Securities, LLC Filing · 2018-10-26Offering 024-10855 Financials · dashboardStatements and reported figures

CNS Pharmaceuticals, Inc.CIK 1729427

Offering timeline

maximum offering · by first filed

2018-06-15 · $17.3M

2018-06-15$17.3M024-10855

Hover a dot or row, or tab through the dots · bars scaled to the largest round ($17.3M)

Offerings

One line per offering, rolled up from all its filings

Offerings
File Number	Filings	First Filed	Last Filed	Price/Security	Securities Offered	Outstanding	Aggregate Offering	Estimated Net	Withdrawn
024-10855	4	2018-06-15	2018-10-26	$6.00	2,875,000	10,536,004	$17.3M	$15.7M	2019-03-28

Equity Classes

Equity classes
Type	Class	Outstanding
common	Common Equity	10,536,004
debt	Convertible notes payable	386,825

Service Providers

Named in the offering statements

Service providers
Role	Provider
auditor	GBH CPAs, PC
legal	Schiff Hardin LLP
underwriter	Boustead Securities, LLC

The statements and reported figures behind CNS Pharmaceuticals, Inc.

Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.

Every caption as the filer wrote it, across every annual report — not just the latest 1-K
Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
A sparkline on each annual-statement line, so the shape is visible before the figures
A revenue series dated to the filings that reported it
A filing history that says what each document contributed, not only that it exists
Follow it, and see it change on your watchlist

Part of the Crowdfunding plan — $40/mo at launch pricing ($100 list)

See plans

External link: SEC Filings ↗